Covered recipient · General Payments record
AMY S SMITH
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,348.67
- Reported across 143 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $672.00 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $341.56 | 17 |
| Phathom Pharmaceuticals, Inc. | $140.12 | 2 |
| ITI, Inc. | $60.49 | 2 |
| PFIZER INC. | $39.66 | 2 |
| Mylan Specialty L.P. | $32.14 | 2 |
| Lilly USA, LLC | $30.49 | 2 |
| Merck Sharp & Dohme Corporation | $14.01 | 1 |
| Acerta Pharma LLC | $13.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.85 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214296 | CMS |
| ABBVIE INC. | $16.72 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214298 | CMS |
| ABBVIE INC. | $25.57 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214300 | CMS |
| ABBVIE INC. | $7.97 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214302 | CMS |
| ABBVIE INC. | $7.38 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214304 | CMS |
| ABBVIE INC. | $11.16 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214306 | CMS |
| ABBVIE INC. | $125.00 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214308 | CMS |
| ABBVIE INC. | $7.86 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214310 | CMS |
| ABBVIE INC. | $12.02 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214312 | CMS |
| ABBVIE INC. | $5.65 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214314 | CMS |
| ABBVIE INC. | $23.05 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214316 | CMS |
| ABBVIE INC. | $10.51 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214318 | CMS |
| ABBVIE INC. | $9.42 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214320 | CMS |
| ABBVIE INC. | $17.19 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214322 | CMS |
| ABBVIE INC. | $7.00 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214324 | CMS |
| ABBVIE INC. | $32.51 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214326 | CMS |
| ABBVIE INC. | $6.70 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108214328 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.53 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104385943 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $43.82 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143605738 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.67 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143605740 | CMS |
| Lilly USA, LLC | $15.34 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135468669 | CMS |
| Lilly USA, LLC | $15.15 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135507938 | CMS |
| Merck Sharp & Dohme LLC | $14.01 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141921836 | CMS |
| Mylan Specialty L.P. | $15.34 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147298380 | CMS |
| Mylan Specialty L.P. | $16.80 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147299194 | CMS |
| PFIZER INC. | $17.98 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131222580 | CMS |
| PFIZER INC. | $21.68 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131953128 | CMS |
| Phathom Pharmaceuticals, Inc. | $125.00 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151206241 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.12 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151206243 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.